Lesion-Function Analysis from Multimodal Imaging and Normative Brain Atlases for Prediction of Cognitive Deficits in Glioma Patients.
brain networks
cognitive testing
glioma
positron emission tomography
radiotherapy
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
14 May 2021
14 May 2021
Historique:
received:
08
04
2021
revised:
09
05
2021
accepted:
10
05
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
3
6
2021
Statut:
epublish
Résumé
Cognitive deficits are common in glioma patients following multimodality therapy, but the relative impact of different types and locations of treatment-related brain damage and recurrent tumors on cognition is not well understood. In 121 WHO Grade III/IV glioma patients, structural MRI,
Identifiants
pubmed: 34069074
pii: cancers13102373
doi: 10.3390/cancers13102373
pmc: PMC8156090
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Behav Neurol. 2020 Mar 25;2020:7941689
pubmed: 32300377
Neuro Oncol. 2021 Jun 1;23(6):881-893
pubmed: 33538838
Science. 2013 Nov 1;342(6158):1238411
pubmed: 24179229
J Neurooncol. 2019 Mar;142(1):79-90
pubmed: 30523605
J Neurooncol. 2020 Jan;146(1):97-109
pubmed: 31802314
Intelligence. 2011 Jul;39(4):222-232
pubmed: 21789028
Clin Neurol Neurosurg. 2018 Apr;167:112-116
pubmed: 29475027
Radiother Oncol. 2016 Aug;120(2):234-40
pubmed: 27418525
JAMA Oncol. 2020 Jul 1;6(7):981-983
pubmed: 32407497
Hum Brain Mapp. 2018 May;39(5):2064-2074
pubmed: 29380489
Neuroimage. 2005 Jul 1;26(3):839-51
pubmed: 15955494
Methods. 2017 Nov 1;130:124-134
pubmed: 28552264
Neuroimage. 2008 Apr 1;40(2):570-582
pubmed: 18255316
Lancet Neurol. 2009 Sep;8(9):810-8
pubmed: 19665931
Korean J Radiol. 2015 Mar-Apr;16(2):286-96
pubmed: 25741190
Neuroimage. 2007 Sep 1;37(3):866-75
pubmed: 17616402
Neurooncol Pract. 2017 Dec;4(4):229-240
pubmed: 31386003
Am J Clin Oncol. 1982 Dec;5(6):649-55
pubmed: 7165009
AJNR Am J Neuroradiol. 2016 Feb;37(2):266-73
pubmed: 26514607
Neurology. 1989 Sep;39(9):1159-65
pubmed: 2771064
J Cogn Neurosci. 2015 Aug;27(8):1471-91
pubmed: 25803596
J Neurooncol. 2019 Sep;144(3):573-582
pubmed: 31410731
Nuklearmedizin. 2011;50(2):74-82
pubmed: 21286660
Psychol Assess. 2001 Jun;13(2):230-9
pubmed: 11433797
Neurosurgery. 2000 Sep;47(3):711-21; discussion 721-2
pubmed: 10981759
Front Psychol. 2018 Jul 06;9:1138
pubmed: 30034354
Radiat Med. 2006 Jun;24(5):345-50
pubmed: 16958412
Front Aging Neurosci. 2014 Jul 14;6:149
pubmed: 25071558
Brain. 2020 Jul 1;143(7):2173-2188
pubmed: 32572442
Front Oncol. 2012 Jul 19;2:73
pubmed: 22833841
J Neurooncol. 2011 May;103(1):111-9
pubmed: 20725847
Trends Cogn Sci. 2017 Dec;21(12):981-996
pubmed: 29100737
Neuroimage. 2012 Aug 15;62(2):782-90
pubmed: 21979382
World Neurosurg. 2019 Jan 3;:
pubmed: 30610982
Lancet Oncol. 2017 Jun;18(6):e315-e329
pubmed: 28483413
Neuro Oncol. 2007 Jan;9(1):53-62
pubmed: 17018697
Cereb Cortex. 2018 Sep 1;28(9):3095-3114
pubmed: 28981612
Ophthalmic Physiol Opt. 2014 Sep;34(5):502-8
pubmed: 24697967
Nat Methods. 2021 Feb;18(2):203-211
pubmed: 33288961
Hum Brain Mapp. 2020 Oct 1;41(14):3970-3983
pubmed: 32588936
Hum Brain Mapp. 2019 Dec 1;40(17):4952-4964
pubmed: 31403237
J Neurooncol. 2014 Jan;116(1):153-60
pubmed: 24173681
Int J Geriatr Psychiatry. 2004 Feb;19(2):136-43
pubmed: 14758579
Innov Clin Neurosci. 2018 Feb 1;15(1-2):36-44
pubmed: 29497579
J Neurosurg. 2012 Nov;117(5):831-8
pubmed: 22937930
Arch Clin Neuropsychol. 2004 Mar;19(2):203-14
pubmed: 15010086
J Nucl Med. 2004 Mar;45(3):374-81
pubmed: 15001676
Radiother Oncol. 2016 Nov;121(2):209-216
pubmed: 27776747
Cortex. 2017 Oct;95:92-103
pubmed: 28865241
Nat Rev Neurosci. 2012 Apr 13;13(5):336-49
pubmed: 22498897
J Neurophysiol. 2011 Sep;106(3):1125-65
pubmed: 21653723
BMC Cancer. 2020 Jun 8;20(1):532
pubmed: 32513138
Brain. 2015 Oct;138(Pt 10):3061-75
pubmed: 26264514
Neuroimage Clin. 2015 Jan 20;7:424-37
pubmed: 25685709
J Cancer Res Ther. 2020 Oct-Dec;16(6):1215-1222
pubmed: 33342776